01 Apr. 2025

Junior Data Manager

Institutional
Application Starts: 01 Apr. 2025

The Informatics Technology Department Unit at the Champalimaud Foundation in Lisbon, is looking for a Junior Data Manager dedicated to designing business intelligence processes and harmonising corporate, medical and research data for extraction of relevant metrics. It will be your job to liaise between the different branches of the institution.

28 Mar. 2025

3D/VR Developer at Centre for Restorative Neurotechnology

Research
Application Starts: 28 Mar. 2025

A Call for one Research fellowship (Bolsa de Investigação) for a 3D/VR Developer is open at Fundação D. Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud (Champalimaud Foundation) in the context of the project entitled “Research Infrastructure for Digital Therapeutics”, with reference “LISBOA2030-FEDER-01316800” from the call Nº “LISBOA2030-2024-15”, funded by the: European Regional Development Fund (ERDF), through the Lisbon Regional Programme 2021-2027.

25 March 2025

In bowel cancer, enlarged lymph nodes can be a good prognostic feature

At the Champalimaud Colorectal Cancer Conference, last February, Gina Brown, from the Imperial College London, questioned the validity of the current staging strategy for colon cancer. Indeed, research shows that lymph nodes are not the main culprit in colon cancer spread, and can actually be a sign that the patient’s immune system is fighting back. 

19 March 2025

Can the microbiome provide information about the risk of developing colorectal cancer and its progression?

Coordinated by Professor Ana Santos Almeida, principal investigator of a translational laboratory at the GIMM Foundation - Gulbenkian Institute for Molecular Medicine (GIMM-CARE), this study will take place at the Champalimaud Foundation, in collaboration with Dr. José Azevedo, surgeon of the Colorectal Cancer Group of the Digestive Unit of the Champalimaud Clinical Center, and at the Hospital de Santa Maria, with the participation of oncologists Professor Luís Costa and Dr. André Mansinho.

Therapeutic Perspectives of Non-invasive Brain Stimulation: the Example of Chronic Pain Management

Host

Albino Oliveira-Maia, MD, PhD, Neuropsychiatry Unit


Venue

Seminar room

Home Sweet Home: Structure and Function of the Neurogenic Niche in Health and Disease

Host

Margarida Caio, Stem Cells and Regeneration Lab


Venue

Seminar room

12 Mar. 2025

Master Student - Oliveira-Maia Lab

Research
Application Starts: 12 Mar. 2025

A Call for one Research Fellow for a Master student is open at Fundação D. Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud (Champalimaud Foundation) in the context of the project entitled “Viscerosensory patwhays in nutrient postingestive signalling”, with reference “PTDC/SAU-NUT/3507/2021” from the call Nº PTDC2021, funded by the Fundação para a Ciência e a Tecnologia (FCT), through Portuguese National Funds (PIDDAC).

12 March 2025

The secret DNA circles fueling Pancreatic Cancer’s aggression

A New Player in Pancreatic Cancer

The team found that some pancreatic cancer cells gain a major survival edge by carrying copies of critical cancer genes—such as MYC—on circular pieces of DNA that exist outside chromosomes, the structures that house most of our genetic material. Known as ecDNA, these genetic rings float freely in the cell nucleus, enabling tumour cells to swiftly ramp up gene expression, change their shape, and survive in otherwise hostile environments.

Under Pressure: How Mechanical Forces Influence Structural Plasticity

Host

Rita Cardoso-Figueiredo, Behavior and Metabolism Lab


Venue

Seminar room

Spatial Omics and AI: Bridging Discovery and Translational Medicine

The "Spatial Omics and AI: Bridging Discovery and Translational Medicine" symposium, is a free event which will explore the impact of Spatial Proteomics and AI in Translational Research and Life Sciences.

Keynote speakers include: 

- Prof. Emma Lundberg (Stanford University)
- Dr. Andrea J. Radtke (Leica Microsystems)
- Dr. Thierry Nordmann (Max Planck Institute)
- Dr. Giuseppe Diaferia (Champalimaud Foundation)

Subscribe to Research Groups
Loading
Please wait...